1. Franzen C, Müller A. Microsporidiosis: human diseases and diagnosis. Microbes Infect. 2001;3(5):389-400. doi: 10.1016/s1286-4579(01)01395-8.
2. Han B, Weiss LM. Therapeutic targets for the treatment of microsporidiosis in humans. Expert Opin Ther Targets. 2018;22(11):903-915. doi: 10.1080/14728222.2018.1538360.
3. Han B, Pan G, Weiss LM. Microsporidiosis in humans. Clin Microbiol Rev. 2021;34(4):e0001020. doi: 10.1128/CMR.00010-20.
4. Gnat S, Łagowski D, Nowakiewicz A, Dyląg M. A global view on fungal infections in humans and animals: opportunistic infections and microsporidioses. J Appl Microbiol. 2021;131(5):2095-
2113. doi: 10.1111/jam.15032.
5. CDC-DPDx. https://www.cdc.gov/dpdx/microsporidiosis/index.html (Erişim tarihi Mayıs 2024)
6. Han Y, Gao H, Xu J, et al. Innate and adaptive immune responses against microsporidia infection in mammals. Front Microbiol. 2020;11:1468. doi: 10.3389/fmicb.2020.01468.
7. Mohamed Yusoff PS, Osman E, Raja Sabudin RZA. Disseminated microsporidiosis: An underdiagnosed and emerging opportunistic disease. Malays J Pathol. 2021;43(1):9-18.
8. Sevim A, Akpınar R, Öztürk SH, et al. PCR-Based screening of pathogens in Bombus terrestris populations of Turkey. Acta Parasitol. 2024;69(1):275-282. doi: 10.1007/s11686-023-00743-5.
9. Santaniello A, Cimmino I, Dipineto L, et al. Zoonotic risk of Encephalitozoon cuniculi in animal-assisted interventions: Laboratory strategies for the diagnosis of ınfections in humans and
animals. Int J Environ Res Public Health. 2021;18(17):9333. doi: 10.3390/ijerph18179333.
10. Ozkan O, Ozkan AT, Zafer K. Encephalitozoonosis in New Zealand rabbits and potential transmission risk. Vet Parasitol. 2011;179(1-3):234-7. doi: 10.1016/j.vetpar.2011.02.007.
11. Çetinkaya Ü, Caner A. Prevalence of microsporidiosis in different hosts in Turkey: A meta-analysis. Turkiye Parazitol Derg. 2020;44(4):232-238. doi: 10.4274/tpd.galenos.2020.7093.
12. Kaya F, İnkaya AÇ, Aksoy S, et al. Investigation of intestinal protozoon prevalence in immunocompromised patients at a university hospital. Turkiye Parazitol Derg. 2021;45(1):39-44. doi:
10.4274/tpd.galenos.2020.6819.
13. Ulusan Bagci O, Muftuoglu C, Guldaval F, et al. Molecular prevalence of microsporidia infection in patients with lung cancer. Am J Trop Med Hyg. 2023;108(5):895-900. doi: 10.4269/ajt-
mh.22-0506.
14. Aydemir S, Halidi AG, Ekici A, Cengiz ZT. Investigation of the presence of Enterocytozoon bieneusi and Encephalitozoon intestinalis in immunosuppressed patients with diarrhea by IFA and
real time PCR methods. Indian J Med Microbiol. 2023;44:100362. doi: 10.1016/j.ijmmb.2023.02.005.
15. Mülayim S, Dalkılıç S, Akbulut HH, Aksoy A, Kaplan M. Investigation of the relationship between lymphocyte subsets and intestinal parasites. Acta Trop. 2022;225:106221. doi: 10.1016/j.
actatropica.2021.106221.
16. Valenčáková A, Sučik M. Alternatives in molecular diagnostics of Encephalitozoon and Enterocytozoon Infections. J Fungi (Basel). 2020;6(3):114. doi: 10.3390/jof6030114.
17. Wei J, Fei Z, Pan G, Weiss LM, Zhou Z. Current therapy and therapeutic targets for microsporidiosis. Front Microbiol. 2022;13:835390. doi: 10.3389/fmicb.2022.835390.
18. Karaman Ü, Kolören Z, Seferoğlu O, Ayaz E, Demirel E. Presence of parasites in environmental waters in Samsun and its districts. Turkiye Parazitol Derg. 2017;41(1):19-21. doi: 10.5152/
tpd.2017.3574